272 related articles for article (PubMed ID: 21840281)
1. First report of introducing population-based breast cancer screening in Poland: experience of the 3-million population region of Lower Silesia.
Matkowski R; Szynglarewicz B
Cancer Epidemiol; 2011 Dec; 35(6):e111-5. PubMed ID: 21840281
[TBL] [Abstract][Full Text] [Related]
2. [The effectiveness of population-based breast cancer screening programme].
Szynglarewicz B; Matkowski R; Kasprzak P; Kotowska J; Forgacz J; Pudełko M; Kornafel J
Pol Merkur Lekarski; 2009 Feb; 26(152):117-20. PubMed ID: 19388515
[TBL] [Abstract][Full Text] [Related]
3. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
4. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
5. Mammography screening in the county of Fyn. November 1993-December 1999.
Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
[TBL] [Abstract][Full Text] [Related]
6. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
[TBL] [Abstract][Full Text] [Related]
7. Mammographic screening programmes in Europe: organization, coverage and participation.
Giordano L; von Karsa L; Tomatis M; Majek O; de Wolf C; Lancucki L; Hofvind S; Nyström L; Segnan N; Ponti A; ; Van Hal G; Martens P; Májek O; Danes J; von Euler-Chelpin M; Aasmaa A; Anttila A; Becker N; Péntek Z; Budai A; Mádai S; Fitzpatrick P; Mooney T; Zappa M; Ventura L; Scharpantgen A; Hofvind S; Seroczynski P; Morais A; Rodrigues V; Bento MJ; Gomes de Carvalho J; Natal C; Prieto M; Sánchez-Contador Escudero C; Zubizarreta Alberti R; Fernández Llanes SB; Ascunce N; Ederra Sanza M; Sarriugarte Irigoien G; Salas Trejo D; Ibáñez Cabanell J; Wiege M; Ohlsson G; Törnberg S; Korzeniewska M; de Wolf C; Fracheboud J; Patnick J J; Lancucki L; Ducarroz S; Suonio E
J Med Screen; 2012; 19 Suppl 1():72-82. PubMed ID: 22972813
[TBL] [Abstract][Full Text] [Related]
8. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.
Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E
Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242
[TBL] [Abstract][Full Text] [Related]
9. Performance indicators evaluation of the population-based breast cancer screening programme in Northern Portugal using the European Guidelines.
Bento MJ; Gonçalves G; Aguiar A; Castro C; Veloso V; Rodrigues V
Cancer Epidemiol; 2015 Oct; 39(5):783-9. PubMed ID: 26315486
[TBL] [Abstract][Full Text] [Related]
10. Attending the breast screening programme after breast cancer treatment: a population-based study.
de Munck L; Kwast A; Reiding D; de Bock GH; Otter R; Willemse PH; Siesling S
Cancer Epidemiol; 2013 Dec; 37(6):968-72. PubMed ID: 24075800
[TBL] [Abstract][Full Text] [Related]
11. Implementation of digital mammography in a population-based breast cancer screening program: effect of screening round on recall rate and cancer detection.
Sala M; Comas M; Macià F; Martinez J; Casamitjana M; Castells X
Radiology; 2009 Jul; 252(1):31-9. PubMed ID: 19420316
[TBL] [Abstract][Full Text] [Related]
12. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
13. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme.
Castells X; Molins E; Macià F
J Epidemiol Community Health; 2006 Apr; 60(4):316-21. PubMed ID: 16537348
[TBL] [Abstract][Full Text] [Related]
14. Dutch digital breast cancer screening: implications for breast cancer care.
Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
[TBL] [Abstract][Full Text] [Related]
15. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet.
Paci E;
J Med Screen; 2012; 19 Suppl 1():5-13. PubMed ID: 22972806
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinomas in situ and invasive cancers detected on screening mammography: Cost-effectiveness of initial and subsequent rounds of population-based program 2007-2014.
Szynglarewicz B; Matkowski R
Adv Clin Exp Med; 2017; 26(2):259-262. PubMed ID: 28791843
[TBL] [Abstract][Full Text] [Related]
17. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
18. Effect of false-positives and women's characteristics on long-term adherence to breast cancer screening.
Román R; Sala M; De La Vega M; Natal C; Galceran J; González-Román I; Baroja A; Zubizarreta R; Ascunce N; Salas D; Castells X
Breast Cancer Res Treat; 2011 Nov; 130(2):543-52. PubMed ID: 21617920
[TBL] [Abstract][Full Text] [Related]
19. [Mammography screening in the county of Copenhagen. Results of the first three screening rounds].
Tange UB; Hirsch FR; Jensen MB; Olsen AH; Blichert-Toft M; Rank FE; Vejborg IM; Mouridsen H; Lynge E
Ugeskr Laeger; 2002 Feb; 164(8):1048-52. PubMed ID: 11894707
[TBL] [Abstract][Full Text] [Related]
20. [Experience in the implementation of screening program for early detection of breast cancer in the Khanty-Mansi Autonomous Region-Yugra].
Zakharova NA
Vopr Onkol; 2013; 59(3):382-5. PubMed ID: 23909042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
